• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LIMITED INTERMEDIATE INFANT OXYGEN THERAPY NASAL CANNULA; CAT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LIMITED INTERMEDIATE INFANT OXYGEN THERAPY NASAL CANNULA; CAT Back to Search Results
Model Number BC2755
Device Problems Detachment Of Device Component (1104); Device Issue (2379)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
The complaint bc2755-20 intermediate infant oxygen therapy nasal cannula is manufactured by salter labs in (b)(4), for fisher & paykel healthcare.We are still endeavouring to retrieve the bc2755-20 cannula.We will provide a follow up report upon completion of our investigation.
 
Event Description
A healthcare facility in (b)(6) reported to via a fisher & paykel healthcare (fph) field representative that the connection between the prongs and tubing of a bc2755-20 intermediate infant oxygen therapy nasal cannula had split.This was found after 2 days of use.There was no patient consequence.
 
Manufacturer Narrative
(b)(4).The complaint (b)(4) intermediate infant oxygen therapy nasal cannula is manufactured by (b)(4), for f&p.Method: the complaint (b)(4) cannula was returned to f&p in new zealand for evaluation where it was visually inspected.Result: visual inspection revealed that the left tube had detached from the nose piece and was coated with a sticky substance.The right tube was attached to the nose piece and was coated with a sticky substance.Conclusion: during manufacture by (b)(4), a bonding agent is applied to the outside surface of the tube and then inserted into the nasal interface.It appears that either insufficient bonding agent was applied to the cannula during manufacturing or that the bonding material applied had not bonded properly.A cannula from a similar complaint was sent to salter labs and they implemented a number of corrective actions including improvement of the gluing process and evaluating and replacing any damaged glue dispensers.The manufacturer of this device has been notified of this complaint and is conducting their own investigation.
 
Event Description
A healthcare facility in canada reported via a fisher & paykel healthcare (f&p) field representative that the connection between the prongs and tubing of a bc2755-20 intermediate infant oxygen therapy nasal cannula had split.This was found after 2 days of use.There was no patient consequence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERMEDIATE INFANT OXYGEN THERAPY NASAL CANNULA
Type of Device
CAT
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LIMITED
15 maurice paykel place
east tamaki
auckland 2013
NZ  2013
MDR Report Key7272190
MDR Text Key100279783
Report Number9611451-2018-00111
Device Sequence Number1
Product Code CAT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/14/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberBC2755
Device Catalogue NumberBC2755
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/13/2018
Was the Report Sent to FDA? No
Date Manufacturer Received01/16/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-